Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 14

List of Figures
Figure No.
Figure Title
Page No.
Figure 41: North America, Smoking Prevalence, Age 15+, 2013-2016 68
Figure 42: United States health care expenditure per capita,2013-2016(USD) 68
Figure 43: Canada health care expenditure per capita,2013-2016(USD) 68
Figure 44: North America population aged 65 and above, 2013-2017 (% of total) 69
Figure 45: North America Healthcare Cost Per Capita, 2017 (USD) 69
Figure 46: North America GDP per Capita, 2013-2017 (USD) 69
Figure 47: North America COPD Drugs Market, By Value, 2018-2023 (USD Million) 70
Figure 48: North America COPD Drugs Market Size, By Drug Type, 2017 (%) 71
Figure 49: North America COPD Drugs Market Size, By Drug Type, 2023F (%) 71
Figure 50: North America COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 72
Figure 51: North America COPD Drugs Market, By Drug Type , By Value, 2018-2023(USD Million) 72
Figure 52: North America COPD Drugs Market Size, By Countries, 2017 (%) 74
Figure 53: North America COPD Drugs Market Size, By Countries, 2023F (%) 74
Figure 54: USA COPD Drugs Market, By Value, 2013-2017 (USD Million) 76
Figure 55: USA COPD Drugs 76
Figure 56: Smoking Prevalence, Age 15+, 2012-2016 78
Figure 57: Canada, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 78
Figure 58: United States Per Capita Spending on Medicines, 2013-2017 (In USD) 79
Figure 59: Pharmacy & Drug Store Sales in United States, 2013-2016 (In USD Billion) 79
Figure 60: Medical and Healthcare Research & Development Spending, 2013-2016 (In USD Million) 79
Market, By Value, 2018-2023(USD Million)
(c) AZOTH Analytics